Open Access
ARTICLE
MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis
* The Third Department of Medical Oncology, The Third Affiliated Hospital of Xinxiang Medical University,
Xinxiang, Henan, P.R. China
† Department of Oncology Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang,
Guangdong, P.R. China
1
These authors are co-first authors.
Oncology Research 2018, 26(6), 913-922. https://doi.org/10.3727/096504017X15135941182107
Abstract
Breast cancer remains a public health issue on a global scale. The present study aimed to explore the functional role of MYB proto-oncogene like 2 (MYBL2) in breast cancer, as well as underlying mechanisms. The regulatory relationship between miR-143-3p and MYBL2 was analyzed, and the effects of dysregulation of miR-143-3p and MYBL2 on cell proliferation and apoptosis were investigated. The results showed that MYBL2 and miR-143-3p were inversely expressed in breast cancer tissues and cells: MYBL2 was highly expressed, whereas miR-143-3p was lowly expressed. MYBL2 was confirmed as a target gene of miR-143-3p. Suppression of MYBL2 inhibited proliferation and induced apoptosis of breast cancer cells, which was similar to the effects of overexpression of miR-143-3p. Our findings reveal that MYBL2 is targeted by miR-143-3p and regulates breast cancer cell proliferation and apoptosis.Keywords
Cite This Article
![cc](https://www.techscience.com/static/images/cc.jpg?t=20230215)